Taichung, Taiwan

Tien-Shen Yang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tien-Shen Yang: Innovator in Cancer Treatment

Introduction

Tien-Shen Yang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cancer treatment. His innovative work focuses on developing methods to inhibit cancer cells, showcasing his commitment to advancing medical science.

Latest Patents

Yang holds a patent for "Antrocin containing pharmaceutical compositions for inhibiting cancer cells." This invention is directed towards a method for the inhibition of cancer cells, which involves administering an effective amount of a compound known as antrocin, or its pharmaceutically acceptable salts, along with a suitable carrier. The cancer cells targeted by this method include colorectal, liver, lung, and breast cancer cells. This patent highlights Yang's dedication to finding effective treatments for various types of cancer.

Career Highlights

Tien-Shen Yang is affiliated with Chaoyang University of Technology, where he contributes to research and development in the pharmaceutical field. His work not only emphasizes innovation but also reflects a strong commitment to improving healthcare outcomes through scientific research.

Collaborations

Yang has collaborated with esteemed colleagues such as Yew-Min Tzeng and Chi-Tai Yeh. These partnerships enhance the research efforts and broaden the impact of their collective work in cancer treatment.

Conclusion

Tien-Shen Yang's contributions to cancer research through his innovative patent demonstrate his significant role in the pharmaceutical industry. His work continues to inspire advancements in medical treatments and offers hope for improved cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…